Optimizing Debridement In Patients On Anticoagulant Therapy Using A Chitosan-Based Hemostatic Agent

Dr. Aliza Lee, staff podiatrist, the Director of Podiatric Medical Education and a clinical investigator at the Salem Veteran Affairs Medical Center in Salem, Virginia talks about her poster, “The Ability to Perform Optimal Debridement in Patients on Anticoagulant Therapy with the Use of a Chitosan-based Hemostatic Agent.” in Podiatry today.

This poster was presented at SAWC Fall 2021.

 

“I think the takeaway message is that you can provide adequate debridement on anticoagulated patient population in the clinic or in the OR setting without fear.”

Dr. Aliza Lee